From: Building an immune-mediated coagulopathy consensus: early recognition and evaluation to enhance post-surgical patient safety
Total
(n = 61)
Mean (days)
32
Median (days)
11
Mode (days)
8
Standard Dev (days)
65.8
95% CI (days)
25–49
Range (days)
5–365